In particular, in this article, we focus on the quantification of NfL in plasma samples in two distinct dementia cohorts: AD, which is well characterized in terms of NfL quantification; and FTD patients, where only a few papers have been published26,27. This evidence concerns the gene NEFL and frontotemporal dementia.